Inloggen
E-mail
Wachtwoord
Paswoord weergeven
Bewaren
Bent u uw wachtwoord vergeten?
Gratis lid worden
Registreer
Registreer
Instellingen
Instellingen
Dynamische koersen 
OFFON

Toonaangevende leiders

Alle informatieOndernemingenMarktenEconomie & ForexgrondstoffenRenteToonaangevende leidersFinanciŽle professionalAgendaSectoren 
HomepaginaAl het nieuwsHet meest gelezen nieuwsBiografieŽn van de Leiders
Portrait de Jerome B. Zeldis
Leeftijd : 70
Vermogen : 521 978 USD
Belangrijkste bedrijven : PTC Therapeutics, Inc. - NexImmune, Inc. - Soligenix, Inc.
Overzicht 
Jerome B. Zeldis is an American businessperson who founded Trek Therapeutics and who has been the head of 5 different companies. Currently, Dr. Zeldis occupies the position of Chairman for Trek Therapeutics, Executive Vice President-Research & Development at NexImmune, Inc. and Chairman & Chief Medical Officer at Viralclear Pharmaceuticals, Inc. Dr. Zeldis is also on the board of 10 other companies.

In his past career he occupied the position of Chairman at MetaStat, Inc., Chief Executive Officer at Celgene Global Health, Chief Medical Officer & President-Regulatory at Sorrento Therapeutics, Inc., Chairman at Alliqua BioMedical, Inc., Chief Medical Officer of Celgene Corp., Chief Medical Officer & Principal at Celularity, Inc. (United States), Associate Director at Sandoz Research Institute, Associate Professor-Medicine at the University of California, Davis, Professor-Clinical Medicine at Robert Wood Johnson Medical School, Clinical Associate Professor at Weill Cornell Medical College, Assistant Professor-Medicine at Harvard Medical School, Assistant Professor at Harvard Medical School and Associate Professor-Medicine at the University of California.

He received a graduate degree and an undergraduate degree from Brown University and a graduate degree and a doctorate from Yale University.


Posities en verantwoordelijkheden van Jerome B. Zeldis 
NaamTitel Van
PTC Therapeutics, Inc.
(Biotechnologie & Medisch Onderzoek)
Independent Director 2012
NexImmune, Inc.
(Biotechnologie & Medisch Onderzoek)
Executive Vice President-Research & Development 2021
Soligenix, Inc.
(Biotechnologie & Medisch Onderzoek)
Independent Director 2011
Trek Therapeutics Chairman 2014
Viralclear Pharmaceuticals, Inc. Chairman & Chief Medical Officer 2020
PTC Corp. Director -
Semorex, Inc. Director -
Central New Jersey Council Boy Scouts of America Director -
Immodulon Therapeutics Ltd. Executive Vice Chairman 2017
NexGel, Inc. Independent Director 2020
Mali Health Organizing Project Director -
International Castlemans Disease Organization Director -
Biond Biologics Ltd. Director 2020


Belangnemingen van Jerome B. Zeldis 
NaamAandelen%Totale waarde
BioSig Technologies, Inc. (BSGM)
(Geavanceerde medische apparatuur & technologie)
107 9440,31%321 673 USD
NexImmune, Inc. (NEXI)
(Biotechnologie & Medisch Onderzoek)
5 8820,026%89 053 USD
PTC Therapeutics, Inc. (PTCT)
(Biotechnologie & Medisch Onderzoek)
2 3370,0033%86 960 USD
Soligenix, Inc. (SNGX)
(Biotechnologie & Medisch Onderzoek)
22 9170,057%24 292 USD


Jerome B. ZeldisPersoonlijk netwerk 
Meest gelezen nieuws 
15/10JACK DORSEY : Square CEO Dorsey zegt op zoek te zijn naar een bitcoin mining systeem - tweet
MR
12/10CATHIE WOOD : ARK Invest's Wood waarschuwt dat aanstaande economische neergang in China 'evident' is
MR
12/10JAMIE DIMON : JPMorgan's Dimon blaast bitcoin af als 'waardeloos', toe aan regulering
MR
13/10WARREN BUFFETT : Door Buffett gesteunde Nubank maakt winst in Brazilië
MR
11/10JAMIE DIMON : JPMorgan's Dimon blaast bitcoin af als 'waardeloos'
MR
07/10ROBERT WALTERS : Recruiter Robert Walters verwacht dat winst hoger zal uitvallen dan ramingen in warme banenmarkt
MR
06/10CARL ICAHN : Dominion verkoopt Questar aan Southwest Gas in een deal van bijna $2 miljard
MR
17/10ELON MUSK : Elon Musk op managementdag Volkswagen
AM
12/10ANNEMIEK VAN MELICK : NN Group haalt Annemiek van Melick als CFO
AM
Meer nieuws


© 2021 People and Ownership :   
Jerome B. Zeldis Verbindingen